Bumper Offer - Urjas oil Just @ Rs. 1
Sporidex Kid 250 Tablet (10) is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Bacterial Infections. Secondary and off-label uses of Sporidex Kid 250 Tablet (10) have also been mentioned below.
The optimal dosage of Sporidex Kid 250 Tablet (10) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Common side effects of Sporidex Kid 250 Tablet (10) include Nausea or vomiting, Allergic reaction, Rash. Besides the aforementioned side effects, there are other adverse effects of Sporidex Kid 250 Tablet (10) as well, which are listed below. Such side effects of Sporidex Kid 250 Tablet (10) normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Sporidex Kid 250 Tablet (10) has a Safe effect for pregnant women and Safe effect on lactating mothers. In addition, Sporidex Kid 250 Tablet (10)'s effects on the liver, heart and kidney are discussed below in the Sporidex Kid 250 Tablet (10) related warnings section.
The section on Sporidex Kid 250 Tablet (10) contraindications lists all such conditions.
Additionally, Sporidex Kid 250 Tablet (10) may also adversely react with other medicines. See below for a complete list.
You should also be aware that Sporidex Kid 250 Tablet (10) is safe while driving, and is addiction.
Sporidex Kid 250 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Sporidex Kid 250 Tablet (10) is used -
Severe
Moderate
Mild
Common
Is the use of Sporidex Kid 250 Tablet (10) safe for pregnant women?
There are no side effects of Sporidex in pregnant women.
Is the use of Sporidex Kid 250 Tablet (10) safe during breastfeeding?
Sporidex does not show any side effects in breastfeeding women.
What is the effect of Sporidex Kid 250 Tablet (10) on the Kidneys?
Sporidex may have mild side effects on the kidneys.
What is the effect of Sporidex Kid 250 Tablet (10) on the Liver?
Using Sporidex does not have any harmful effects on the liver.
What is the effect of Sporidex Kid 250 Tablet (10) on the Heart?
You can take Sporidex without any fear of damage to the heart.
Sporidex Kid 250 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Sporidex Kid 250 Tablet (10) unless your doctor advises you to do so -
Is this Sporidex Kid 250 Tablet (10) habit forming or addictive?
Forming a habit of Sporidex Kid 250 Tablet (10) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Sporidex Kid 250 Tablet (10) will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Sporidex Kid 250 Tablet (10) should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Sporidex Kid 250 Tablet (10) for mental disorders.
Interaction between Food and Sporidex Kid 250 Tablet (10)
Taking Sporidex Kid 250 Tablet (10) with food does not cause any problems.
Interaction between Alcohol and Sporidex Kid 250 Tablet (10)
It is difficult to say anything about the effect of Sporidex Kid 250 Tablet (10) and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
